6
Journal of Chemical Research 00(0)
Figure 6. Point analysis of the ZnO@CuO@Iron ore NCs.
Furthermore, the SEM micrograph shown in Figure 5 Declaration of conflicting interests
demonstrates a nanosized system (mostly in the range of
The author(s) declared no potential conflicts of interest with
50–70nm) for the ZnO@CuO@Iron ore NCs, including a
semi-spherical shape and homogeneous morphology with
some agglomeration on the surface of the nanostructure.
Also, the point analysis of a determined section of the
nanocatalyst shows peaks related to the Fe, O, Zn, Si, and
Cu, thereby confirming the successful anchoring of the
CuO and ZnO NPs on the iron ore substrate and fabrication
of the ZnO@CuO@Iron ore NCs (Figure 6).
respect to the research, authorship, and/or publication of this
article.
Funding
The author received no financial support for the research, author-
ship, and/or publication of this article.
ORCID iD
S Mohammad Sajadi
Preparation of α-
aminophosphonates
References
A mixture of a carbonyl compound, an amine, and diethyl
phosphite (each of 1mmol) was added to the ZnO@CuO@
Iron ore NCs (15mg) at 100°C. The progress of the reac-
tion was monitored by thin-layer chromatography (TLC)
(mobile phase EtOAc/n-hexane, 20:80). On completion of
the reaction, EtOAc (2× 20mL) was added and the catalyst
was separated with a simple magnet. The organic solvent
was removed under reduced pressure. After purification by
chromatography on silica gel (EtOAc/n-hexane, 20:80) the
α-aminophosphonate was obtained and characterized. All
the products are known compounds and the spectral data
and melting points were identical to those reported in the
literature.21,23,26–30
1. Karmakar B, Paul S and Banerji J. ARKIVOC 2011; ii: 161.
2. Sajadi SM, Kolo K, Hamad SM, et al. Mor J Chem 2019; 7: 12.
3. Du S, Faiger H, Belakhov V, et al. Bioorg Med Chem 1997;
7: 2671.
4. Bear JC, Yu B, Blanco-Andujar C, et al. Faraday Discuss
2014; 175: 83.
5. Sajadi SM, Kolo K, Hamad SM, et al. ChemistrySelect 2018;
3: 12274.
6. Sajadi SM, Kolo K, Abdullah SM, et al. J Surf Interfac 2018;
13: 205.
7. Sajadi SM, Kolo K, Hamad SM, et al. IET-Nanobiotechnol
2018; 13: 124.
8. Sajadi SM, Kolo K, Pirouei M, et al. RSC Adv 2018; 8:
35557.
9. Sajadi SM, Khalaj M, Mohammadi B, et al. Synth Commun
2011; 41: 3053.
10. Sajadi SM and Maham M. Lett Org Chem 2013; 10: 136.
11. Allen M, Fuhrer CW, Tuck B, et al. J Med Chem 1989; 32:
1652.
Dimethyl (phenyl)-N-(phenyl)aminomethylphosphonate
1
(Table 2, entry 2); H NMR δH (500MHz, CDCl3): δ 3.50
(d, 3H, J=10.5Hz), 3.80 (d, 3H, J=10.5Hz), 4.81 (1H, d,
J=24Hz), 4.84 (s, 1H, br), 6.65 (d, 2H, J=8.0Hz), 6.75 (t,
1H, J=7.2Hz), 7.10 (t, 2H, J=7.6Hz), 7.30 (t, 1H,
J=7.5Hz), 7.40 (t, 2H, J=7.4Hz), 7.51 (d, 2H, J=7.4Hz);
12. Giannousis PP and Bartlett PA. J Med Chem 1987; 30: 1603.
13. Bartlett PA and Kezer WB. J Am Chem Soc 1984; 106: 4282.
14. Laschat S and Kunz H. Synthesis 1992; 90.
15. Genet JP, Yziel J, Port M, et al. Tetrahedron Lett 1992; 33:
77.
2
13C NMR (125MHz, DMSO-d6): δ 54.2 (d, OCH3, JP–
2
1
C =7.0Hz), 54.2 (OCH3, JP–C =6.8Hz), 56.2 (d, CH, JP–
C =150Hz), 114.2 (CH), 119.0 (CH), 128.3 (d, CH,
3
3JP–C =5.8Hz), 128.4 (d, CH, JP–C =3.1Hz), 129.2 (CH),
16. Qian C and Huang T. J Org Chem 1998; 63: 4125.
17. Ranu BC, Hajra A and Jana U. Org Lett 1999; 1: 1141.
131.2 (CH), 136.1 (C), 146.6 (d, C, 2JP–C =14.5Hz).